Download
s13014-021-01902-6.pdf 914,69KB
WeightNameValue
1000 Titel
  • Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma
1000 Autor/in
  1. Gollrad, Johannes |
  2. Rabsahl, Christopher |
  3. Riechardt, Aline-Isabel |
  4. Heufelder, Jens |
  5. Stroux, Andrea |
  6. Goerling, Ute |
  7. Joussen, Antonia |
  8. Budach, Volker |
  9. Boehmer, Dirk |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-09-08
1000 Erschienen in
1000 Quellenangabe
  • 16(1):174
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13014-021-01902-6 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425039/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Proton beam therapy is a well-established treatment option for patients with uveal melanoma (UM). The treatment procedure, in general, includes placing radiopaque clips to ensure exact eye-positioning during radiotherapy, followed by the delivery of proton irradiation. The short-term burden associated with proton therapy in patients with UM has rarely been addressed. In this prospective study, we investigated the physiological and psychological aspects of proton therapy that might affect the well-being of patients during the different stages of treatment.!##!Methods!#!During the treatment procedure, we conducted longitudinal assessments of the Quality of life (QOL), organ-specific symptoms, and psychological aspects in patients with UM with three questionnaires (EORTC QLQ-C30, EORTC QLQ-OPT30, and GAD-7). Patients completed questionnaires before clip surgery (T0), before proton therapy (T1), after completing treatment (T2), and three months after treatment completion (T3). We also collected data on tumor characteristics and socio-demographics to identify potential risk factors associated with high treatment burdens.!##!Results!#!We prospectively included 131 consecutive patients. Questionnaire data showed a significant, temporary decline in global QOL and an increase in eye-related symptoms, as a result of the clip surgery (T0-T1). After treatment completion (T2), global QOL improved gradually, and none of the eye-related symptoms significantly deteriorated over the course of proton therapy. The global QOL returned to baseline levels three months after treatment (T3). We identified baseline anxiety as an independent risk factor for experiencing an acute treatment-related burden. Furthermore, we found interactions between GAD7 and patient sex showing that anxiety had a more pronounced effect on QOL outcome in female patients.!##!Conclusion!#!The short-term treatment-related burden of ocular proton therapy appeared to be largely associated with the preceding clip surgery, rather than the irradiation procedure. We found that anxiety was strongly associated with experiencing QOL issues during the treatment procedure. Our findings could contribute to the development of future strategies for improving the treatment process and psycho-oncologic patient care.
1000 Sacherschließung
lokal Female [MeSH]
lokal Aged, 80 and over [MeSH]
lokal Proton Therapy/adverse effects [MeSH]
lokal Aged [MeSH]
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal Melanoma/radiotherapy [MeSH]
lokal Clinical Radiation Oncology
lokal Middle Aged [MeSH]
lokal Melanoma/psychology [MeSH]
lokal Proton therapy
lokal Proton Therapy/methods [MeSH]
lokal Quality of life
lokal Male [MeSH]
lokal Uveal Neoplasms/radiotherapy [MeSH]
lokal Quality of Life [MeSH]
lokal Research
lokal Young Adult [MeSH]
lokal Uveal melanoma
lokal Uveal Neoplasms/psychology [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0003-0853-144X|https://frl.publisso.de/adhoc/uri/UmFic2FobCwgQ2hyaXN0b3BoZXI=|https://frl.publisso.de/adhoc/uri/UmllY2hhcmR0LCBBbGluZS1Jc2FiZWw=|https://frl.publisso.de/adhoc/uri/SGV1ZmVsZGVyLCBKZW5z|https://frl.publisso.de/adhoc/uri/U3Ryb3V4LCBBbmRyZWE=|https://frl.publisso.de/adhoc/uri/R29lcmxpbmcsIFV0ZQ==|https://frl.publisso.de/adhoc/uri/Sm91c3NlbiwgQW50b25pYQ==|https://frl.publisso.de/adhoc/uri/QnVkYWNoLCBWb2xrZXI=|https://frl.publisso.de/adhoc/uri/Qm9laG1lciwgRGlyaw==
1000 Hinweis
  • DeepGreen-ID: 2c67dca7ede74c4588233ba9b52a901d ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6463457.rdf
1000 Erstellt am 2023-11-15T18:45:09.202+0100
1000 Erstellt von 322
1000 beschreibt frl:6463457
1000 Zuletzt bearbeitet 2023-11-30T21:42:21.461+0100
1000 Objekt bearb. Thu Nov 30 21:42:21 CET 2023
1000 Vgl. frl:6463457
1000 Oai Id
  1. oai:frl.publisso.de:frl:6463457 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source